Surgical oncology, handled with clinical precision.
SurgOnc Today® is a professional surgical oncology show built around case-aware discussion, research context, and career realities. Recent episodes move between contract negotiation, cooperative group trials, AI guardrails, breast cancer studies, GLP-1 counseling, and early detection work in Angola.
PRESS PLAY
SurgOnc Today® sits squarely inside the working world of surgical oncology. It is specialty copy with its sleeves rolled up. The show moves from hospital contracts to cooperative group trials, from AI tools to axillary lymph node management, and from endocrine counseling to cancer detection programs in Angola. Recent episodes show a strong preference for practical clinical judgment. Speakers repeatedly frame treatment decisions as case-dependent, shaped by patient factors, institutional policy, data quality, and the limits of current evidence. Career development is part of the same landscape. Episodes on first and second contracts spend time on non-competes, salary differences, leadership opportunities, documentation of contributions, and the question of what actually supports long-term success. The tone is professional and deliberate. It rarely chases drama. Instead, it lets specialists work through the kind of details that determine whether a decision is useful in clinic, research, or an academic career. The AI episode is a good example of the show’s range. It treats large language models as possible tools for records, trial eligibility, and literature triage, while keeping HIPAA compliance and patient data protection in view. The breast cancer episodes lean into trial interpretation and surgical decision-making. Discussions of axillary dissection, nodal burden, adjuvant therapy, radiation, and non-surgical management stay close to the evidence described by the speakers. The GLP-1 episode brings a similar discipline to counseling around thyroid nodules, medullary thyroid cancer, MEN2, pancreatitis, and precautionary stopping points. The Angola conversation adds a different but related register. It addresses early detection, literacy, beliefs about cancer, women’s access to care, resource limits, and the work of building trust through consistent local practice. That breadth matters. SurgOnc Today® is not only about operative choices or journal findings; it is about the systems around those choices. The show’s editorial center is clear: surgical oncology as a clinical, research, educational, and professional discipline. Its best moments come when experienced voices translate complexity into decisions that a surgeon, trainee, or cancer-care professional can carry into real work.
Made for: Suits a listener who wants surgical oncology conversations with practical clinical, research, and career relevance. It is especially well matched to people comfortable with specialist terminology and patient-care context.
What sets it apart: The show keeps clinical evidence, institutional constraints, and professional development in the same conversation. Similar medical shows may focus on papers or interviews; SurgOnc Today® often connects those topics to how surgical oncologists actually practice, counsel, negotiate, and build programs.
SurgOnc Today® is an educational podcast for cancer surgeons from the Society of Surgical Oncology. Each episode features conversations with individuals who are experts within their respective fields and are members of SSO.
The AI promise comes with a HIPAA firewall, in case your enthusiasm brought a patient chart.
Press play if you want
Short reviews from the PlayNext desk, based on the episodes we processed.
A practical discussion of why the second contract can shape a surgical oncologist's long-term career path.
Negotiating a second contract becomes less about a simple salary comparison and more about whether the role can support the next stage of a surgical oncologist's career. Robin Schmitz leads Dr. Rajesh Ramanathan and Dr.
A grounded look at AI in surgical oncology, from patient-data guardrails to tools still moving toward clinical use.
SurgOnc Today looks at artificial intelligence as a practical tool for surgical oncology, from summarizing faxes and medical records to identifying clinical-trial eligibility factors and sorting cancer-genetics papers.
A clear, practical guide to protecting the terms that matter in a first contract.
A first contract can shape the move from training into independent practice, and this practical episode treats negotiation as a question of priorities, not bravado.
A grounded guide to how surgeons enter cooperative groups and shape ideas for multidisciplinary clinical trials.
SurgOnc Today frames cooperative-group research as something surgeons can actually navigate, connecting disease-site committees, task forces, concept development, and clinical-trial design to day-to-day surgical practice.
A data-led surgical review of TACSIS, axillary lymph node dissection, and the narrow path toward non-surgical management.
SurgOnc Today tracks breast surgeons through the surgical takeaways from the 2025 San Antonio Breast Cancer Symposium, with attention to axillary management, de-escalation strategies, imaging, and TACSIS.
Brain science before it becomes a headline.
SurgOnc Today’s “Negotiating Your Second Contract” centers on Robin Schmitz’s conversation with Dr.
SurgOnc Today® brings Dr.
Lily Sadat, an assistant attending surgeon at Memorial Sloan Kettering Cancer Center, hosts Dr.
SurgOnc Today® brings together Flavio Roca, Dr.
SurgOnc Today® covers the 2025 San Antonio Breast Cancer Symposium with Eri Bonc, Dr.
SurgOnc Today's panel on the newly updated PSM Consortium Guidelines brings Deepa McGee, Rupin Shah, Kiran Turaga, Laura Lambert, Brian Badwell, Garrett Nash, Sean Deneen, and John Kunzman into one discussion.
Breast surgeons discuss updated ASCO guidelines for sentinel lymph node biopsy in early-stage breast cancer, focusing on de-escalation based on SOUND and ENSEMA trials.
This episode reviews the Collision trial, a phase 3 randomized study that changes treatment for colorectal liver metastases, as part of the 2025 HPB Wrapped series.
This episode discusses the molecular approaches to understanding ampullary adenocarcinoma, a rare and poorly understood GI tumor, with expert Dr.
Dr.
Breast surgical oncologist Kelly Hewitt hosts three medical oncologists to discuss early-stage breast cancer highlights from the ASCO annual meeting, focusing on HER2-positive disease management.